Controversies Regarding Subclinical Leaflet Thrombosis After TAVR

Published: 12 November 2020
Likes: 2
Average (rating)
No ratings
Your rating

Overview

A substantial number of patients develops a subclinical leaflet thrombosis (SLT) after transcatheter aortic valve replacement (TAVR).

The thrombus forms on the leaflets, which can lead to valve dysfunction and possibly to early valve degeneration. Multidetector computed tomography is the most sensitive imaging technique at detecting SLT.

Patients on antiplatelet drugs are at higher risk to develop SLT as compared to those on anticoagulant. During the live debate, the experts in the field will discuss controversies concerning SLT, including the routine use of oral anticoagulants and CT exams after TAVR.

Learning Objectives

  • To learn about the natural history, incidence and clinical implications of SLT
  • To learn about the mechanisms that may lead to SLT
  • To understand the diagnostic criteria SLT
  • To discuss the prevention and treatment options for SLT

Audience

  • Interventional cardiologists with focus on TAVR procedures
  • Cardiac Imaging specialists (Echocardiography, Computer Tomography)
  • General cardiologists
  • Specialists interested in management of antithrombotic therapies after TAVR

Agenda

Program

Lecture: Subclinical leaflet thrombosis after TAVR: Numbers and facts Jolanta Siller-Matula

Patients should receive routine CT screening after TAVR to exclude subclinical valve thrombosis

Debate 1: Introduction Jolanta Siller-Matula
Debate 1: PRO Mamas Mamas
Debate 1: CONTRA Poonam Velagapudi
Debate 1: Panel discussion Panel

Patients should be routinely discharged on oral anticoagulants for prevention of subclinical valve thrombosis after TAVR

Introduction Jolanta Siller-Matula
Debate 2: PRO Kimberly Atianzar
Debate 2: CONTRA Renate Schnabel
Debate 2: Panel discussion Panel